Bank of Montreal’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-137,500
| Closed | -$24.4M | – | 3464 |
|
|
2024
Q4 | $24.4M | Hold |
137,500
| – | – | 0.01% | 664 |
|
|
2024
Q3 | $26.8M | Buy |
137,500
+25,000
| +22% | +$4.67M | 0.01% | 676 |
|
|
2024
Q2 | $19.3M | Hold |
112,500
| – | – | 0.01% | 777 |
|
|
2024
Q1 | $20.3M | Buy |
+112,500
| New | +$19.4M | 0.01% | 734 |
|
|
2021
Q3 | – | Sell |
-45,000
| Closed | -$5.07M | – | 3790 |
|
|
2021
Q2 | $5.07M | Buy |
45,000
+39,400
| +704% | +$4.44M | ﹤0.01% | 1605 |
|
|
2021
Q1 | $594K | Sell |
5,600
-4,400
| -44% | -$471K | ﹤0.01% | 2534 |
|
|
2020
Q4 | $1.09M | Buy |
+10,000
| New | +$961K | ﹤0.01% | 2187 |
|
|
2020
Q3 | – | Sell |
-49,100
| Closed | -$4.81M | – | 4739 |
|
|
2020
Q2 | $4.81M | Sell |
49,100
-75,100
| -60% | -$6.61M | ﹤0.01% | 1182 |
|
|
2020
Q1 | $9.33M | Buy |
+124,200
| New | +$10.6M | 0.01% | 727 |
|
|
2019
Q4 | – | Sell |
-36,000
| Closed | -$2.73M | – | 4835 |
|
|
2019
Q3 | $2.73M | Buy |
+36,000
| New | +$2.47M | ﹤0.01% | 1484 |
|
|
2019
Q2 | – | Sell |
-32,200
| Closed | -$2.6M | – | 4829 |
|
|
2019
Q1 | $2.6M | Sell |
32,200
-42,000
| -57% | -$3.44M | ﹤0.01% | 1523 |
|
|
2018
Q4 | $6.84M | Buy |
+74,200
| New | +$6.53M | 0.01% | 933 |
|
|
2018
Q3 | – | Sell |
-2,300
| Closed | -$213K | – | 4706 |
|
|
2018
Q2 | $213K | Buy |
+2,300
| New | +$225K | ﹤0.01% | 2730 |
|
|
2017
Q2 | – | Sell |
-100,000
| Closed | -$6.52M | – | 4128 |
|
|
2017
Q1 | $6.52M | Buy |
+100,000
| New | +$6.29M | 0.01% | 964 |
|
|
2016
Q2 | – | Sell |
-500
| Closed | -$29K | – | 4052 |
|
|
2016
Q1 | $29K | Buy |
+500
| New | +$27.9K | ﹤0.01% | 3244 |
|
|
2015
Q3 | – | Sell |
-140,000
| Closed | -$9.41M | – | 3961 |
|
|
2015
Q2 | $9.41M | Buy |
+140,000
| New | +$9.14M | 0.01% | 838 |
|
|
2015
Q1 | – | Sell |
-17,150
| Closed | -$1.12M | – | 3951 |
|
|
2014
Q4 | $1.12M | Sell |
17,150
-11,247
| -40% | -$709K | ﹤0.01% | 1661 |
|
|
2014
Q3 | $1.64M | Buy |
+28,397
| New | +$1.58M | ﹤0.01% | 1561 |
|
|
2014
Q2 | – | Sell |
-3,082
| Closed | -$158K | – | 4647 |
|
|
2014
Q1 | $158K | Buy |
+3,082
| New | +$156K | ﹤0.01% | 2601 |
|
|
2013
Q4 | – | Sell |
-4,550
| Closed | -$204K | – | 3707 |
|
|
2013
Q3 | $204K | Buy |
4,550
+1,550
| +52% | +$68.7K | ﹤0.01% | 2235 |
|
|
2013
Q2 | $124K | Buy |
+3,000
| New | +$131K | ﹤0.01% | 2353 |
|
Other funds holding ABBV
VCM
VPM
Bank of Montreal's ABBV Position: Q1 2026 in Review
Bank of Montreal reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $31.7M and leaving 3,078,495 shares worth $670M. The position accounts for 0.25% of the portfolio, ranked #74.
Bank of Montreal first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $793M in Q3 2024. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank of Montreal held 3,078,495 shares of AbbVie worth $670M as of Q1 2026.
- Bank of Montreal sold 142,726 AbbVie shares in Q1 2026, an estimated $31.7M.
- AbbVie made up 0.25% of Bank of Montreal's portfolio in Q1 2026, its #74 holding.
- Bank of Montreal first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's AbbVie position peaked at $793M in Q3 2024.
- 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.